Fresenius Medical Care AG KGaA Current Ratio 2010-2024 | FMS
Current and historical current ratio for Fresenius Medical Care AG KGaA (FMS) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Fresenius Medical Care AG KGaA current ratio for the three months ending September 30, 2024 was 1.37.
| Fresenius Medical Care AG KGaA Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $8.90B | $6.48B | 1.37 |
| 2024-06-30 | $9.36B | $6.39B | 1.46 |
| 2024-03-31 | $10.08B | $6.74B | 1.50 |
| 2023-12-31 | $9.42B | $6.62B | 1.42 |
| 2023-09-30 | $9.86B | $7.20B | 1.37 |
| 2023-06-30 | $9.10B | $7.22B | 1.26 |
| 2023-03-31 | $9.19B | $6.97B | 1.32 |
| 2022-12-31 | $8.64B | $6.81B | 1.27 |
| 2022-09-30 | $8.57B | $6.40B | 1.34 |
| 2022-06-30 | $8.63B | $7.32B | 1.18 |
| 2022-03-31 | $9.02B | $7.16B | 1.26 |
| 2021-12-31 | $9.43B | $8.59B | 1.10 |
| 2021-09-30 | $9.43B | $8.84B | 1.07 |
| 2021-06-30 | $9.42B | $8.95B | 1.05 |
| 2021-03-31 | $9.39B | $8.73B | 1.08 |
| 2020-12-31 | $8.31B | $7.04B | 1.18 |
| 2020-09-30 | $9.15B | $8.23B | 1.11 |
| 2020-06-30 | $9.01B | $8.88B | 1.02 |
| 2020-03-31 | $8.67B | $9.49B | 0.91 |
| 2019-12-31 | $8.03B | $7.85B | 1.02 |
| 2019-09-30 | $8.04B | $8.21B | 0.98 |
| 2019-06-30 | $8.06B | $8.12B | 0.99 |
| 2019-03-31 | $8.52B | $8.36B | 1.02 |
| 2018-12-31 | $9.27B | $7.40B | 1.25 |
| 2018-09-30 | $8.76B | $7.04B | 1.25 |
| 2018-06-30 | $8.96B | $6.55B | 1.37 |
| 2018-03-31 | $8.41B | $6.67B | 1.26 |
| 2017-12-31 | $7.21B | $5.99B | 1.20 |
| 2017-09-30 | $7.80B | $6.40B | 1.22 |
| 2017-06-30 | $7.45B | $5.84B | 1.28 |
| 2017-03-31 | $7.54B | $5.73B | 1.32 |
| 2016-12-31 | $7.31B | $5.04B | 1.45 |
| 2016-09-30 | $7.22B | $5.25B | 1.37 |
| 2016-06-30 | $7.28B | $4.92B | 1.48 |
| 2016-03-31 | $7.15B | $4.45B | 1.61 |
| 2015-12-31 | $6.77B | $4.15B | 1.63 |
| 2015-09-30 | $6.76B | $3.94B | 1.72 |
| 2015-06-30 | $6.70B | $3.62B | 1.85 |
| 2015-03-31 | $6.60B | $3.55B | 1.86 |
| 2014-12-31 | $6.72B | $3.48B | 1.93 |
| 2014-09-30 | $6.46B | $4.30B | 1.50 |
| 2014-06-30 | $6.81B | $3.69B | 1.85 |
| 2014-03-31 | $6.50B | $3.45B | 1.89 |
| 2013-12-31 | $6.29B | $3.55B | 1.77 |
| 2013-09-30 | $6.04B | $3.39B | 1.78 |
| 2013-06-30 | $6.15B | $3.41B | 1.81 |
| 2013-03-31 | $6.00B | $3.30B | 1.82 |
| 2012-12-31 | $6.13B | $3.17B | 1.93 |
| 2012-09-30 | $5.94B | $3.35B | 1.77 |
| 2012-06-30 | $6.06B | $5.87B | 1.03 |
| 2012-03-31 | $6.09B | $5.89B | 1.04 |
| 2011-12-31 | $5.70B | $4.26B | 1.34 |
| 2011-09-30 | $5.59B | $3.69B | 1.51 |
| 2011-06-30 | $5.82B | $3.62B | 1.61 |
| 2011-03-31 | $5.72B | $3.47B | 1.65 |
| 2010-12-31 | $5.15B | $3.79B | 1.36 |
| 2010-09-30 | $5.35B | $3.77B | 1.42 |
| 2010-06-30 | $4.95B | $5.05B | 0.98 |
| 2010-03-31 | $4.79B | $4.02B | 1.19 |
| 2009-12-31 | $4.73B | $2.61B | 1.81 |
| 2009-09-30 | $4.73B | $2.64B | 1.79 |
| 2009-06-30 | $4.49B | $2.81B | 1.60 |
| 2009-03-31 | $4.23B | $3.00B | 1.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.386B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| AxoGen (AXGN) | United States | $0.688B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.142B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |